Statement of changes in beneficial ownership of securities Submitted by amarin on Wed, 07/03/2019 - 00:10 Home Read more about Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities Submitted by amarin on Wed, 07/03/2019 - 00:08 Home Read more about Statement of changes in beneficial ownership of securities
Report of unscheduled material events or corporate event Submitted by amarin on Tue, 07/02/2019 - 12:18 Home Read more about Report of unscheduled material events or corporate event
Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance Submitted by amarin on Tue, 07/02/2019 - 10:00 Home Read more about Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance
Statement of changes in beneficial ownership of securities Submitted by amarin on Thu, 06/27/2019 - 00:13 Home Read more about Statement of changes in beneficial ownership of securities
Amarin’s John Thero Awarded NJ EY Entrepreneur of The Year® 2019 Award for Life Sciences Submitted by amarin on Fri, 06/21/2019 - 17:39 Home Read more about Amarin’s John Thero Awarded NJ EY Entrepreneur of The Year® 2019 Award for Life Sciences
Statement of changes in beneficial ownership of securities Submitted by amarin on Fri, 06/21/2019 - 00:08 Home Read more about Statement of changes in beneficial ownership of securities
2019 BMO Prescription For Success Healthcare Conference Submitted by amarin on Tue, 06/18/2019 - 11:49 Home Read more about 2019 BMO Prescription For Success Healthcare Conference
Amarin to Present at the 2019 BMO Prescription For Success Healthcare Conference Submitted by amarin on Tue, 06/18/2019 - 11:00 Home Read more about Amarin to Present at the 2019 BMO Prescription For Success Healthcare Conference
Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting Submitted by amarin on Fri, 06/07/2019 - 14:57 Home Read more about Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting
